BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Aspirin, rs7903146, BRCA1, T cell receptor signaling pathway, Obesity, Lymphocyte)
Bookmark Forward

QuickView for CTNNB1 (gene)


Body Atlas

Most Correlated Tissues

  1. Cerebellar vermis
  2. Endometrium
  3. Myometrium
  4. Cerebellum
  5. Ileum mucosa
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Hypoxia
  2. Liver cancer
  3. Bacterial pneumonia
  4. Skin cancer
  5. Poisoning by drug AND/OR medicinal substance
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
  2. Plasma Gases
  3. Argon
  4. Saquinavir
  5. Thalidomide
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR4717
  2. MIR142
  3. EIF2AK1
  4. ROR1
  5. MIR10A
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. The Role of CTNNB1 in Endometrial Cancer.
  2. CTNNB1 (β-CATENIN) VITREORETINOPATHY: IMAGING CHARACTERISTICS AND SURGICAL MANAGEMENT.
  3. Clinicopathologic Evaluation of CTNNB1 Mutations in High-Intermediate Risk Endometrial Endometrioid …
  4. Role of m6A modification in dysregulation of Wnt/β-catenin pathway in cancer.
  5. PD-L1 interacts with Frizzled 6 to activate β-catenin and form a positive feedback loop to promote c…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Hyperekplexia in Patients With CTNNB1 Mutation
  2. Genotype-phenotype Correlations in Children and Adults With CTNNB1 Mutation
  3. National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITU…
  4. Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive…
  5. Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients
Explore Clinical Trials Results
  • Copyright © 2023 Illumina Inc. All rights reserved.